Search

everythinglearnresearchcommunity

for

Search:↓

Some stem cells in the body rarely divide, which could help create better treatments for diseases and aging.

Cell-based therapies show promise for treating Limbal Stem Cell Deficiency but need more research.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Understanding facial anatomy and early management are key to preventing and treating complications from injectable fillers.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Tissue stiffness affects hair follicle regeneration, and Twist1 is a key regulator.

Taking tamsulosin or finasteride and being older increase the risk of floppy iris during cataract surgery.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Finasteride effectively prevents biofilm formation and treats preformed biofilms, but requires high doses.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

The document explains how to do skin procedures, care after surgery, and when to use certain treatments.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Gintonin-enriched fraction promotes hair growth and could be a potential alopecia treatment.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Researchers found that certain lipids, especially vitamin D3, are lower in prematurely grey hair than in pigmented hair.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.